Syon Capital LLC Purchases Shares of 3,286 Prestige Consumer Healthcare Inc. (NYSE:PBH)

Syon Capital LLC bought a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 3,286 shares of the company's stock, valued at approximately $257,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter valued at approximately $27,000. CIBC Private Wealth Group LLC grew its position in shares of Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after acquiring an additional 152 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth approximately $40,000. GAMMA Investing LLC grew its position in shares of Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock worth $108,000 after acquiring an additional 220 shares during the last quarter. Finally, Huntington National Bank grew its position in shares of Prestige Consumer Healthcare by 133.2% during the fourth quarter. Huntington National Bank now owns 1,481 shares of the company's stock worth $116,000 after acquiring an additional 846 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Canaccord Genuity Group raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Tuesday. Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada boosted their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research note on Friday, March 21st. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $93.33.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded up $0.92 during mid-day trading on Thursday, reaching $82.15. The company had a trading volume of 155,122 shares, compared to its average volume of 288,277. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The company has a market capitalization of $4.07 billion, a P/E ratio of 19.20, a P/E/G ratio of 2.69 and a beta of 0.47. The stock's 50-day simple moving average is $83.39 and its 200-day simple moving average is $80.74.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.